Werner Linkesch

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Jürgen Finke, Wolfgang Bethge, Claudia Schmoor et al. · The Lancet Oncology · 2009 · 705 citations

Unrelated Donors, Graft-versus-host Disease, Transplantation +12

Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells

Katharina Schallmoser, Christina Bartmann, Eva Rohde et al. · Transfusion · 2007 · 503 citations

MDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia

Robert Pirker, J. Wallner, Werner Linkesch et al. · JNCI Journal of the National Cancer Institute · 1991 · 361 citations

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.

J. Beyer, A. Kramar, Romeo A. Mandanas et al. · Journal of Clinical Oncology · 1996 · 319 citations

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

Gèrard Socié, Claudia Schmoor, Wolfgang Bethge et al. · Blood · 2011 · 302 citations · Full text